Genertec Universal Medical Group Company Limited (Stock Code: 2666) announced the completion of the public issuance of the fourth tranche of corporate bonds (T4 Corporate Bonds) by its wholly-owned subsidiary China Universal Leasing Co., Ltd. on December 4, 2025. The total principal amount stands at RMB1 billion.

The T4 Corporate Bonds carry a basic term of five years starting from December 4, 2025, with a fixed interest rate of 2.25%. At the end of the third and fourth year, the issuer retains a repurchase option and may adjust the coupon rate, while bondholders hold a sell-back option. The issue price is RMB100 per bond, equivalent to 100% of the principal value.